WHO Expands Contraceptive Horizons: New Male Options Expected in 10 Years

Introduction

The World Health Organisation has unveiled expanded contraceptive guidance, signaling a major shift in global family planning strategy. With new male contraceptive candidates on the horizon and revised recommendations for existing methods, the updates aim to give people more control, flexibility, and choice.

What Happened

On September 23, 2026, WHO published new guidelines expanding contraceptive options for both women and men. The release coincides with World Contraception Day and emphasizes that access to a broader range of methods can help close the gap for the 164 million women worldwide who want to avoid pregnancy but aren't currently using contraception.

The guidance covers extended-use combined oral pills, longer-lasting implants, and the addition of mifepristone as an emergency contraception option. Perhaps most significantly, WHO confirmed it is actively supporting the development of reversible male contraceptives, which could become available within five to ten years.

Why This Matters

For decades, contraceptive responsibility has disproportionately fallen on women. The new guidelines acknowledge that men and women alike benefit from a wider method spectrum. Evidence shows that over 75% of surveyed couples would consider using a new male method, and more than 85% of women would trust their partners to share that responsibility.

Beyond individual choice, the impact reaches public health. Increased method variety typically lowers unplanned pregnancy rates, reduces reliance on fewer options, and supports gender equity in reproductive decision-making.

Key Takeaways

\n
• Expanded access: WHO's new guidelines expand contraceptive access, including extended-pill use up to one year and implants effective for up to five years.
\n
• Emergency option: Mifepristone is now recommended as an emergency contraception option, effective within five days of unprotected sex.
\n
• Male pipeline: Reversible male contraceptives are in advanced development and could reach markets in the next five to ten years.
\n
• Couple readiness: Survey data indicates strong willingness among couples to adopt new male methods, with majority support from both partners.
\n
• Research roadmap: WHO is developing a Target Product Profile to guide future male contraceptive research, focusing on safety, effectiveness, and affordability.
\n

Conclusion

The WHO's updated guidance marks a pivotal moment in reproductive health policy. By expanding options for all genders and investing in next-generation male methods, the organization is helping to ensure that contraception is more accessible, acceptable, and aligned with real-world needs. As these developments unfold, the focus will remain on translating research into equitable, widely available solutions.